Submitted by Anonymous (not verified) on 11 June 2024 - 14:45
Human medicines European public assessment report (EPAR): GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.), budesonide,formoterol fumarate dihydrate, Date of authorisation: 03/04/2020, Revision: 5, Status: Authorised
Source: